Evidence map›Paper›PMID 42358712›Full record

ArticleJACS Au2026

From Batch to Continuous Operation: Hydrogenation of Bicarbonate to Formate at Multiphase Boundaries in a Continuous Stirred-Tank Reactor.

Mariko Inoue, Gul Afreen, Kazuhito Wada, Matteo Tafuro, Kodai Nogami, Evgeny A Uslamin, Atul Bansode, Hideaki Tsuneki, Makoto Hirano, Atsushi Urakawa

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JACS Au, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mariko InoueSeparation Technology Research Center, Corporate Research and Development Division, Nitto Denko Corporation, 1-1-2 Ibaraki, Osaka 567-8680, Japan.ORCID https://orcid.org/0000-0002-0752-5593
Gul AfreenCatalysis Engineering, Department of Chemical Engineering, Delft University of Technology, Van der Maasweg 9, Delft 2629 HZ, The Netherlands.
Kazuhito WadaSeparation Technology Research Center, Corporate Research and Development Division, Nitto Denko Corporation, 1-1-2 Ibaraki, Osaka 567-8680, Japan.
Matteo TafuroCatalysis Engineering, Department of Chemical Engineering, Delft University of Technology, Van der Maasweg 9, Delft 2629 HZ, The Netherlands.
Kodai NogamiSeparation Technology Research Center, Corporate Research and Development Division, Nitto Denko Corporation, 1-1-2 Ibaraki, Osaka 567-8680, Japan.
Evgeny A UslaminCatalysis Engineering, Department of Chemical Engineering, Delft University of Technology, Van der Maasweg 9, Delft 2629 HZ, The Netherlands.ORCID https://orcid.org/0000-0001-5454-9582
Atul BansodeCatalysis Engineering, Department of Chemical Engineering, Delft University of Technology, Van der Maasweg 9, Delft 2629 HZ, The Netherlands.ORCID https://orcid.org/0000-0002-1972-6704
Hideaki TsunekiDepartment of Applied Chemistry, Waseda University, 3-4-1, Okubo, Shinjuku, Tokyo 169-8555, Japan.
Makoto HiranoSeparation Technology Research Center, Corporate Research and Development Division, Nitto Denko Corporation, 1-1-2 Ibaraki, Osaka 567-8680, Japan.ORCID https://orcid.org/0009-0004-3008-1670
Atsushi UrakawaCatalysis Engineering, Department of Chemical Engineering, Delft University of Technology, Van der Maasweg 9, Delft 2629 HZ, The Netherlands.ORCID https://orcid.org/0000-0001-7778-4008

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The utilization of carbon dioxide (CO

Indexed as

catalyst recyclingCO2 conversioncontinuous stirred-tank reactorhydrogenationkinetic modelRu complex

Identifiers

PMID42358712
PMCPMC13292002

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.